Puts small labs' reports on ABDM so patients' records follow them
TL;DR Labbridge hooks small diagnostic labs and imaging centres into India's Ayushman Bharat Digital Mission. It turns the reports they already print into records patients can pull into their ABHA app. Labs pay a monthly fee, and both sides pick up government incentives for every linked record.
India's health-ID drive has run way ahead of its records. As of July 2026 there were about 94 crore ABHA accounts and about 105 crore linked records[1][2], which by our arithmetic is barely one record per account. Your blood tests, scans and prescriptions most likely still live on paper or inside some lab's own portal.
Labs are the weakest link, and the money shows it. Of what the Digital Health Incentive Scheme had paid by June 2026, hospitals got ₹107 crore while labs, diagnostics and pharmacies together got only ₹2.95 crore[1]. That's a huge gap.
Most small labs run basic billing software or plain spreadsheets, and nobody on staff has the time to handle a national integration.
First, the regulatory bit - Labbridge does record formatting and consent-based sharing only. It does not read, interpret or flag results, so it is not a medical device. It is health-data software that has to meet the DPDP Act and pass ABDM's sandbox and milestone certification.
Here's how it works. Labbridge plugs into the lab's existing report output and converts each finished report into the standard format ABDM expects, then links it to the patient's ABHA at billing through a QR scan and serves it when the patient approves a request from a doctor or hospital. The lab owner gets a dashboard of linked records and incentive claims.
The seed wanted blockchain, and I don't think it needs it. India already has a consent-based exchange where records stay with whoever created them and no central server holds them[1]. A second ledger would only duplicate that, and an unchangeable record sits badly with the DPDP Act's right to have data corrected or erased[3]. So Labbridge keeps the goal and rides the national rails.
The patient benefits but pays nothing. The lab owner pays a monthly subscription, and since the scheme gives software companies 25% of the incentive their facility clients earn[4], Labbridge gets paid twice. What should the fee be? We found no published price for ABDM integration aimed at small labs, because vendors quote on request. Your sprint has to find the monthly fee a 2–5 staff lab will accept.
Three things moved in 2026. A government backgrounder in July set out incentives for labs and software companies[1]. From July 2026, incentives need the v3 versions of ABDM milestones M1 to M3, plus a security audit for software firms[5]. And PM-JAY now shows hospital incentives as inactive when a hospital's software falls short of milestones M1 and M2[6], so labs that serve those hospitals will feel the pull too.
Nobody publishes a figure for what labs spend on ABDM integration. The firmest signal is the incentive gap - ₹2.95 crore paid to labs, pharmacies and diagnostics against ₹107 crore to hospitals[1]. Next door, One market research firm puts India's electronic health records market at US$739.3M in 2025 (about ₹7,151 Cr)[7]. That is mostly hospital software, so treat it as context and not your market.
One Indian health-records startup offers clinics an EMR with ABDM linking and record sharing[8]. The government's own eSushrut@Clinic, launched June 2026, gives small clinics a free lightweight HMIS and had onboarded 2,200 facilities[1]. Hospital software vendors and ABDM integrators go after bigger buyers. None of them is built around the small lab's day, and the incentive payouts show exactly where that gap is.
| Difficulty | Moderate (41/100) |
| Starting capital | ₹60 L–1.2 Cr |
| Time to launch | 6–9 months |
The standards work is documented and the sandbox is open, so the tech won't sink you. The field will. You're dealing with thousands of small labs with odd report formats, owners who don't trust new software and incentive claims that show up late, and every lab you onboard needs someone on site at least once.
No operating licence as such, because it isn't a medical device. Health-data rules and ABDM certification are the gate.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't let AI read or interpret results. Labbridge formats and shares records only, and the moment it flags results it becomes a different, regulated product.
Want to work out the AI layer for Labbridge? Talk to Yash →
Here's what can go south -
I like this one because it's practical and pretty unglamorous, which is usually a good sign. It suits a founder who knows lab operations or has sold software to small clinics. If you're set on blockchain or on fast venture-scale growth then this is not for you.
Before anything else, prove that 20 labs in one city will pay a monthly fee and link most of their reports within 60 days.
My estimate is ₹60 L–1.2 Cr, covering the software, ABDM certification and a sales team for one or two cities. The kit has the detail.
No operating licence, but you must clear ABDM's sandbox and milestone certification, and the DPDP Act applies in full.
Yes, if the country has a national health-record exchange to plug into. Check its certification and data rules with your local regulator first.
The free Labbridge validation kit has the line-by-line capital breakdown, the effort scoring, the ABDM and data-protection checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for lab owners, and 5 assumptions to test. Download the kit →
Thinking about building Labbridge or something close to it? The make-or-break work is onboarding small labs cheaply enough that the fee and incentives cover it, and that's the kind of thing I enjoy working through with founders. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.